Boston Partners’s Apyx Medical APYX Stock Holding History

Boston Partners’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-142,608	Closed	-$620K	–	704
2018 Q2	$620K	Buy	+142,608	New	+$526K	﹤0.01%	763

Other funds holding APYX

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Horizon Kinetics New York $3.06B AUM 5.37% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Boston Partners's APYX Position: Q3 2018 in Review

Boston Partners sold out of Apyx Medical (APYX) in Q3 2018, closing a stake of 142,608 shares — an estimated $620K sold.

Boston Partners first reported a position in APYX in Q2 2018 and held it in 1 quarter. The position peaked at $620K in Q2 2018. 56 funds tracked by Wall St. Rank hold APYX as of Q3 2018.

Boston Partners reported no remaining Apyx Medical position as of Q3 2018 after selling out during the quarter.
Boston Partners sold 142,608 Apyx Medical shares in Q3 2018, an estimated $620K.
Boston Partners first reported a position in Apyx Medical in Q2 2018 and held it in 1 quarter.
Boston Partners's Apyx Medical position peaked at $620K in Q2 2018.
56 funds tracked by Wall St. Rank held Apyx Medical as of Q3 2018.

Based on Boston Partners's 13F filing for Q3 2018, filed 14 Nov 2018.